汇宇制药: 董事会决议公告

Group 1 - The board of directors of Sichuan Huiyu Pharmaceutical Co., Ltd. held its 17th meeting on August 25, 2025, via telecommunication, with all 8 directors present and unanimously agreeing on the meeting's agenda and procedures [1][2] - The board approved the proposal to sign a national general agency agreement for the product "TY-9591," with a voting result of 7 votes in favor, 0 abstentions, and 0 against [1][2] - The board also decided not to convene a shareholders' meeting to review the related matters at this time, with a voting result of 8 votes in favor, 0 abstentions, and 0 against [2]